A multicentre, randomized, split face and/or neck comparison of 308‐nm excimer laser and 0·1% tacrolimus ointment for stable vitiligo plus intramuscular slow‐releasing betamethasone for active vitiligo

Authors :: Yunhao Wu
Keping Chen
Jun-Wu Zhang
X.-H. Gao
Hui Li
Heng Gu
Hongyi Wang
L. Qiu
Yingxian Sun
Y. Zhang
Source :: British Journal of Dermatology. 181:210-211
Publication Year :: 2019
Publisher :: Oxford University Press (OUP), 2019.

Subjects :: medicine.medical_specialty
business.industry
Treatment outcome
Dermatology
Vitiligo
medicine.disease
Tacrolimus
law.invention
Randomized controlled trial
Multicenter study
law
308 nm excimer laser
medicine
Betamethasone
business
medicine.drug

Tools